These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35504861)

  • 41. Memory deficits in Parkinson's disease are associated with reduced beta power modulation.
    MacDonald HJ; Brittain JS; Spitzer B; Hanslmayr S; Jenkinson N
    Brain Commun; 2019; 1(1):fcz040. PubMed ID: 32090200
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression.
    Fereshtehnejad SM; Zeighami Y; Dagher A; Postuma RB
    Brain; 2017 Jul; 140(7):1959-1976. PubMed ID: 28549077
    [TBL] [Abstract][Full Text] [Related]  

  • 43. REM Sleep Behavior Disorder in Parkinson's Disease: Effects on Cognitive, Psychiatric, and Functional outcomes.
    Mahmood Z; Van Patten R; Nakhla MZ; Twamley EW; Filoteo JV; Schiehser DM
    J Int Neuropsychol Soc; 2020 Oct; 26(9):894-905. PubMed ID: 32375913
    [TBL] [Abstract][Full Text] [Related]  

  • 44. How do episodic and semantic memory contribute to episodic foresight in young children?
    Martin-Ordas G; Atance CM; Caza JS
    Front Psychol; 2014; 5():732. PubMed ID: 25071690
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hippocampal correlates of episodic memory in Parkinson's disease: A systematic review of magnetic resonance imaging studies.
    Pourzinal D; Yang JHJ; Bakker A; McMahon KL; Byrne GJ; Pontone GM; Mari Z; Dissanayaka NN
    J Neurosci Res; 2021 Sep; 99(9):2097-2116. PubMed ID: 34075634
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
    Rolinski M; Fox C; Maidment I; McShane R
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Texture features of magnetic resonance images: A marker of slight cognitive deficits in Parkinson's disease.
    Betrouni N; Lopes R; Defebvre L; Leentjens AFG; Dujardin K
    Mov Disord; 2020 Mar; 35(3):486-494. PubMed ID: 31758820
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of Rhythmic Interventions on Cognitive Abilities in Parkinson's Disease.
    Roesch AD; Gschwandtner U; Handabaka I; Meyer A; Taub E; Fuhr P
    Dement Geriatr Cogn Disord; 2021; 50(4):372-386. PubMed ID: 34808624
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Are non-demented patients with Parkinson's disease able to decide about their own treatment?
    Eygelshoven S; van den Hout A; Tucha L; Fuermaier ABM; Bangma DF; Thome J; Lobbestael J; Tucha O; Koerts J
    Parkinsonism Relat Disord; 2017 May; 38():48-53. PubMed ID: 28262511
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Social cognition impairments in Parkinson's disease].
    Lyashenko EA; Iakovleva OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9. Vyp. 2):37-43. PubMed ID: 31825388
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Social problem solving, social cognition, and mild cognitive impairment in Parkinson's disease.
    Anderson RJ; Simpson AC; Channon S; Samuel M; Brown RG
    Behav Neurosci; 2013 Apr; 127(2):184-92. PubMed ID: 23067384
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Retrograde Procedural Memory in Parkinson's Disease: A Cross-Sectional, Case-Control Study.
    Pauly L; Pauly C; Hansen M; Schröder VE; Rauschenberger A; Leist AK; Krüger R;
    J Parkinsons Dis; 2022; 12(3):1013-1022. PubMed ID: 35147550
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cognitive and behavioral disorders in Parkinson's disease: an update. I: cognitive impairments.
    Papagno C; Trojano L
    Neurol Sci; 2018 Feb; 39(2):215-223. PubMed ID: 29043468
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical phenotype of drug-naïve Parkinson's disease based on nonmotor symptoms.
    Lee HM; Lee SS; Kim M; Kang SH; Seo WK; Kim JH; Koh SB
    Arch Gerontol Geriatr; 2015; 61(3):517-22. PubMed ID: 26183203
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Motor learning, retention and transfer after virtual-reality-based training in Parkinson's disease--effect of motor and cognitive demands of games: a longitudinal, controlled clinical study.
    dos Santos Mendes FA; Pompeu JE; Modenesi Lobo A; Guedes da Silva K; Oliveira Tde P; Peterson Zomignani A; Pimentel Piemonte ME
    Physiotherapy; 2012 Sep; 98(3):217-23. PubMed ID: 22898578
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cognitive training interventions for dementia and mild cognitive impairment in Parkinson's disease - A cochrane review summary with commentary.
    Loetscher T
    NeuroRehabilitation; 2021; 48(3):385-387. PubMed ID: 33780379
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Using executive heterogeneity to explore the nature of working memory deficits in Parkinson's disease.
    Lewis SJ; Cools R; Robbins TW; Dove A; Barker RA; Owen AM
    Neuropsychologia; 2003; 41(6):645-54. PubMed ID: 12591022
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differences in cognitive performance in nondemented Parkinson's disease: A latent profile analysis of cognitive subtypes.
    Alonso-Recio L; Martín-Plasencia P; Ruiz M; Serrano JM
    J Clin Exp Neuropsychol; 2018 Oct; 40(8):777-789. PubMed ID: 29429384
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Virtual Reality Functional Capacity Assessment Tool (VRFCAT-SL) in Parkinson's Disease.
    Turner TH; Atkins A; Keefe RSE
    J Parkinsons Dis; 2021; 11(4):1917-1925. PubMed ID: 34334421
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuropsychological prediction of dementia in Parkinson's disease.
    Mahieux F; Fénelon G; Flahault A; Manifacier MJ; Michelet D; Boller F
    J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):178-83. PubMed ID: 9489527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.